Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 71335-2602

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 71335-2602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Image 01)

Chemical structure of diltiazem hydrochloride showing its molecular arrangement including aromatic rings, sulfur, nitrogen, and hydrochloride (HCl) components.*

FDA Label Image

Image (Image 02)

Data table showing adverse reactions in placebo-controlled angina and hypertension trials of diltiazem hydrochloride extended-release capsules 180 mg. The table compares incidence percentages of headache, dizziness, bradycardia, AV block first degree, edema, and asthenia between diltiazem hydrochloride extended-release capsules (n=607) and placebo (n=301).*

FDA Label Image

Label (Lbl713352602)

Label for diltiazem hydrochloride Extended-Release Capsules, USP 180 mg, displaying the NDC 71335-2602-1. The label specifies it contains 30 capsules and is for prescription use only. It notes storage instructions and warnings about moisture and dizziness. The product is repackaged by Bryant Ranch Prepack, Inc. and manufactured by Novast Laboratories, Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.